About a week ago the United States Court of Appeals for the DC Circuit told a lower court that it was wrong to dismiss out of hand and must reconsider a claim "whether the Due Process Clause [of the U.S. Constitution] protects the right of terminally ill patients to decide, without FDA interference, to assume the risks of using potentially life-saving i…
Keep reading with a 7-day free trial
Subscribe to The Objective Standard to keep reading this post and get 7 days of free access to the full post archives.